The White House and HHS have reached out to NACDS to help share the national public education campaign with pharmacies, and in turn, NACDS is urging the federal government do their part as the nation enters the fall respiratory illness season.
2024 NACDS Total Store Expo welcomes NACDS chain and supplier members to Boston with impressive conference schedule; opportunities to come together to collaborate, innovate and confront industry pressures.
Social campaign underscores the importance of fall vaccinations to help manage infectious diseases.
Award recognizes NACDS Initiatives in Food is Medicine Programming in Response to White House Conference on Hunger, Nutrition, and Health
New Pharmacy Workgroup within Sequoia’s “Interoperability Matters” program aims to foster and broaden clinical interoperability for pharmacies across the healthcare ecosystem; aligns with NACDS’ vision for the future of pharmacy and retail health
HB 1993 includes important PBM reforms and protections for Pennsylvania families’ access to pharmacies for important services.
NACDS’ Nourish Ny Health initiative, a newly released Milken Institute Action Plan, and a Leavitt Partners report on pharmacy data interoperability are among the latest.
NACDS: “The Congress and states need no further validation for their bipartisan work to immediately confront pharmaceutical benefit manipulation that is devastating Americans, communities, and pharmacies of all sizes”
NACDS: “These harms are experienced brutally by pharmacies of diverse sizes and formats, including independents and chains, that do not receive preferential treatment from their vertically integrated plans and PBMs”
“Now is the time for Massachusetts to stop pharmaceutical benefit manipulation from inflating Bay Staters’ prescription drug prices and from jeopardizing access to trusted pharmacies and needed medications”
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part”
HB 579 will improve critical community access to care by enabling pharmacists to dispense HIV pre-exposure (PrEP) and post-exposure prophylaxis (PEP); becomes effective on August 1, 2024
